Comparison of genomic damage caused by 5-nitrofurantoin in young and adult mice using the in vivo micronucleus assay

Environmental and Molecular Mutagenesis

Volumn 46, Issue 1, 2005, Pages 59-63

  Fučić, Aleksandra ^a   Marković, Darko ^b   Ferenčić, Zeljko ^b   Mildner, Boris ^b   Jazbec, Ana Marija ^c   Špoljar, Jadranka Bubić ^b  

^a INSTITUTE FOR MEDICAL RESEARCH AND OCCUPATIONAL HEALTH   (Croatia)

^b PLIVA Research Institute Ltd   (Croatia)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

5 nitrofurantoin; Development; Mice; Micronucleus assay

Indexed keywords

ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE; NITROFURANTOIN; XENOBIOTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; DETOXIFICATION; DNA DAMAGE; DOSE RESPONSE; DRUG CLEARANCE; DRUG ELIMINATION; DRUG METABOLISM; FEMALE; GENOTOXICITY; IN VIVO STUDY; MALE; MICRONUCLEUS TEST; NONHUMAN; RETICULOCYTE;

AGING; ANALYSIS OF VARIANCE; ANIMALS; ANTI-INFECTIVE AGENTS, URINARY; FEMALE; MALE; METABOLIC DETOXICATION, DRUG; MICE; MICE, INBRED BALB C; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; NITROFURANTOIN; RETICULOCYTES; TIME FACTORS;

ANIMALIA;

EID: 23244450096     PISSN: 08936692     EISSN: None     Source Type: Journal    
DOI: 10.1002/em.20129     Document Type: Article

References (42)

1. Alcorn J, McNamara PJ. 2002. Ontogeny of hepatic and renal systemic clearance pathways in infants. Clin Pharmacokinet 41:959-998.
2. Arancibia V, Valderrama M, Madariaga A, Zuniga MC, Segura R. 2003. Extraction of nitrofurantoin and its toxic metabolite from urine by supercritical fluids. Quantitation by high performance liquid chromatography with UV detection. Talanta 61:377-383.
3. Bandow JE, Brotz H, Leichen LIO, Labischinski H, Hecker M. 2003. Proteomic approach to understanding antibiotic action. Antimicrob Agents Chemother 47(3):948-955.
4. Braunlich H, Bonow A, Schroter S. 1978. Age-dependence of renal tubular reabsorption of nitrofurantoin. Arch Int Pharmacodyn Ther 232:92-101.
5. Cohen SM. 1998. Urinary bladder carcinogenesis. Toxicol Pathol 26:121-127.
6. Eckel PM, Ortner A, Esterbauer H. 1993. Genotoxic properties of 4-hydroxyalkenals and analogous aldehydes. Mutat Res 290(2):183-192.
7. Esterbauer H, Zollner H, Schaur RJ. 1991. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehyde. Free Radic Biol Med 11:81-128.
8. Fonatsch C. 1977. Effect of nitrofurantoin on meiosis of the male mouse. Hum Genet 39:345-351.
9. Fucic A, Marković D, Ferenčić Ž. 2003. Micronucleus induction in mouse peripheral reticulocytes by 5-nitrofurantoin. EEMS Book of abstracts:49-50.
10. Gerk PM, Kuhn RJ, Desai NS, McNamara PJ. 2001. Active transport of nitrofurantoin into human milk. Pharmacotherapy 21(6):669-675.
11. Ginsberg G, Hattis P, Sonawane B, Russ A, Banati P, Kozlak M, Smolenski S, Goble R. 2002. Evaluation of child/adult pharmacokinetic differences from a database derived from the therapeutic drug literature. Toxicol Sci 66(2):185-200.
12. Gram TE. 1997. Chemically reactive intermediates and pulmonary xenobiotic toxicity. Pharmacol Rev 49(4):297-341.
13. Hayashi M, Morita T, Kodama Y, Sofuni T, Ishidate M. 1990. The micronucleus assay with mouse peripheral blood reticulocyte using acridine orange-coated slides. Mutat Res 245:245-249.
14. Johansson SL, Cohen SM. 1997. Epidemiology and etiology of bladder cancer. Semin Surg Oncol 13(5):291-298.
15. Kamat AM, Lamm DL. 1999. Chemoprevention of urological cancer. J Urol 161(6):1748-1760.
16. Klee S, Nurnberger MC, Ungemach FR. 1994. The consequences of nitrofurantoin-induced oxidative stress in isolated rat hepatocytes: evaluation of pathobiochemical alterations. Chem Biol Interact 93(2):91-102.
17. Laval J. 1996. Role of DNA repair enzymes in the cellular resistance to oxidative stress. Pathol Biol 44(1):14-24.
18. Leitner A, Zollner P, Lindner W. 2001. Determination of the metabolites of nitrofuran antibiotics in animal tissue by high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr A 939:49-58.
19. Leskovac V, Popović M. 1980. Mechanism of reduction of nitrofurantoin on liver microsomes. Pharmacol Res Commun 12:13-27.
20. Lundquist G, Morgenstern R. 1995. Ontogenesis of rat liver microsomal glutathione transferase. Biochem Pharmacol 50(3):421-423.
21. Martinez PG, Winston GW, Metash-Dickey C, O'Hara SCM, Livingstone DR. 1995. Nitrofurantoin stimulated reactive oxygen species production and genotoxicity in digestive gland microsomes and cytosol of the common mussel (Mytilus edulis, L.) Toxicol Appl Pharm 131:332-341.
22. Michielis C, Remacle J. 1988. Quantitative study of natural antioxidant systems for cellular nitrofurantoin toxicity. Bichim Biophys Acta 967(3):341-347.
23. Minchin RF, Ho PC, Boyd MR. 1986. Reductive metabolism of nitrofurantoin by rat lung and liver in vitro. Biochem Pharmacol 35(4):575-580.
24. Morita T, Asano N, Awogi T, Sasaki Yu F, Sato S, Shimada H, Sutou S, Suzuki T, Wakata A, Sofuni T, Hayashi M. 1997 Evaluation of the rodent micronucleus assay in the screening of IARC carcinogens (Groups 1, 2A and 2B). The summary report of the 6th collaborative study by CSGMT/JEMS MMS. Mutat Res 389(1):3-114.
25. National Toxicology Program. 1989. Toxicology and carcinogenisis studies of nitrofurantoin, in F344/N rats and B6C3F1 mice. National Institute of Health, Technical Report Series No 341, NIH Publication 89-2597.
26. Neely MD, Sidel KR, Graham DG, Montine TJ. 1999. The lipid peroxidation product 4-hydroxynonenal inhibits neurite outgrowth, disrupts neuronal microtubules and modifies cellular tubulin. J Neurochem 72(6):2323-2333.
27. Ni YC, Heflich RH, Kadlubar FF, Fu PP. 1987. Mutagenicity of nitrofurans in Salmonella typhimurium TA98, TA98NR and TA98/1,8-DNP6. Mutat Res 192:15-22.
28. Olivard J, Valenti S, Buzard JA. 1962. The metabolism of 5-nitro-2-furaldehyde acetyl hydrazone. J Med Pharm Chem 5:524-531.
29. Olivero A, Miglietta A, Gadoni E, Gabriel L. 1990. 4-Hydroxynonenal interacts with tubulin by reacting with its functional-SH groups. Cell Biochem Funct 8(2):99-105.
30. Ono H, Sakamoto A, Sakura N. 2001. Plasma total glutathione concentrations in healthy pediatric and adult subjects. Clin Chim Acta 312:227-229.
31. Parodi S, Pala M, Russo P, Balbi C, Abelmoschi ML, Taningher M, Zunino A, Ottaggio L, De Ferrari M, Carbone A, Santi L. 1983. Alkaline DNA fragmentation, DNA disentanglement evaluated viscosimetrically and sister chromated exchanges, after treatment in vivo with nitrofurantoin. Chem Biol Interact 45:77-94.
32. Slapšyte G, Lazutka JR. Lekevicius RK. 1996. Genotoxic activity of two uroantiseptic nitrofurans in a battery of short-term tests. Biologija (Lithuania) 2:78-82.
33. Slapšyte G, Jankauskiene A, Mierauskiene J, Lazutka JR. 2002. Cytogenetic anaylsis of peripheral blood lymphocytes of children treated with nitrofurantoin for recurrent urinary tract infection. Mutagen 17(1):31-35.
34. Sokal RR, Rohlf FJ. 1995. Biometry. New York: Freeman & Company.
35. Statham CN, Minchin RF, Sasame HA, Kim SH, Boyd MR. 1985. Effect of vitamin E on the distribution and metabolism of nitrofurantoin in rats. Drug Metab Dispos 13(5):532-534.
36. Steineck G, Wilholm BE, Gerhardson de Verdier M. 1995. Acetaminophen some other drugs, some disease and the risk of transitional cell carcinoma. A population-based case-control study. Acta Oncol 34:741-748.
37. Thompson ED. 1986. Comparison of in vivo and in vitro cytogenetic assay results. Environ Mutagen 8:753-767.
38. Wierzba K, Wankowicz B, Rogoyski A, Prokopczyk A, Kaminska E, Bozkowa K. 1982. Experimental and clinical pharmacokinetics of nitrofurantoin in the early period of life. Padiatr Padol 17(2):293-299.
39. Wierzba K, Wankowitcz B, Prokopczyk J, Piekarczyk A. 1984. Pharmacokinetics of nitrofurantoin in the bodies of pregnant rats. Probl Med Wieku Rozwoj 13:185-192.
40. Wiseman H, Halliwell B. 1996. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory diseases and progression to cancer. Biochem J 313:17-29.
41. Yang Y, Sharma R, Sharma A, Awasthi S, Awasthi YC. 2003. Lipid peroxidation and cell signaling: 4-hydroxynonenal, a key molecule in stress mediated signaling. Acta Biochim Pol 50(2):319-336.
42. Žarković N. 2001. Some biomedical aspects of oxidative stress and 4-hydroxynonenal. Progress Report of the 1. Regional Meeting of the HNE Club, 7-8 June 2001, Zagreb. Croatia. pp 3-4.